Dr. Reddy's eyes aspirational goal to be in top five in the Indian market

Dr. Reddy's Laboratories is prioritizing innovative product launches through strategic partnerships to achieve a 15-16% growth in the Indian market. The company's focus includes expanding its portfolio with new products, growing existing brands, and strengthening its consumer health segment. Recent successes include the launch of toripalimab and upcoming respiratory vaccine and allergy product launches.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/A7yYGrU
via IFTTT